Lung cancer: diagnosis and management (NG122)Product type:GuidanceProgramme:NICE guidelineLast updated: 8 March 2024Published: 28 March 2019
Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 23 June 2015
Durvalumab for adjuvant treatment of resectable non-small-cell lung cancer [ID1263]Status:In developmentProgramme:NICE guidelineExpected publication date: TBC